Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma

Abstract We present the case of a 50‐year‐old male patient with metastatic clear cell renal cell carcinoma (mRCC) who developed a diffuse pulmonary opacification and lymphadenopathy during nivolumab maintenance therapy. This was diagnosed as presumed sarcoid granulomatous inflammatory reaction secon...

Full description

Bibliographic Details
Main Authors: Victoria Purcell, Beatrice Preti, Ricardo Fernandes
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.5960
_version_ 1811312342924787712
author Victoria Purcell
Beatrice Preti
Ricardo Fernandes
author_facet Victoria Purcell
Beatrice Preti
Ricardo Fernandes
author_sort Victoria Purcell
collection DOAJ
description Abstract We present the case of a 50‐year‐old male patient with metastatic clear cell renal cell carcinoma (mRCC) who developed a diffuse pulmonary opacification and lymphadenopathy during nivolumab maintenance therapy. This was diagnosed as presumed sarcoid granulomatous inflammatory reaction secondary to immunotherapy, which resolved with holding off therapy and the nivolumab was resumed.
first_indexed 2024-04-13T10:35:39Z
format Article
id doaj.art-25f07734dd5143afb77f18428a371aca
institution Directory Open Access Journal
issn 2050-0904
language English
last_indexed 2024-04-13T10:35:39Z
publishDate 2022-07-01
publisher Wiley
record_format Article
series Clinical Case Reports
spelling doaj.art-25f07734dd5143afb77f18428a371aca2022-12-22T02:50:04ZengWileyClinical Case Reports2050-09042022-07-01107n/an/a10.1002/ccr3.5960Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinomaVictoria Purcell0Beatrice Preti1Ricardo Fernandes2Schulich School of Medicine and Dentistry Western University London Ontario CanadaSchulich School of Medicine and Dentistry Western University London Ontario CanadaSchulich School of Medicine and Dentistry Western University London Ontario CanadaAbstract We present the case of a 50‐year‐old male patient with metastatic clear cell renal cell carcinoma (mRCC) who developed a diffuse pulmonary opacification and lymphadenopathy during nivolumab maintenance therapy. This was diagnosed as presumed sarcoid granulomatous inflammatory reaction secondary to immunotherapy, which resolved with holding off therapy and the nivolumab was resumed.https://doi.org/10.1002/ccr3.5960immune‐related adverse eventsimmunotherapymetastatic renal cell carcinomasarcoid‐like reactions
spellingShingle Victoria Purcell
Beatrice Preti
Ricardo Fernandes
Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
Clinical Case Reports
immune‐related adverse events
immunotherapy
metastatic renal cell carcinoma
sarcoid‐like reactions
title Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
title_full Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
title_fullStr Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
title_full_unstemmed Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
title_short Suspected immune checkpoint inhibitor‐induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
title_sort suspected immune checkpoint inhibitor induced pulmonary sarcoid reaction in metastatic renal cell carcinoma
topic immune‐related adverse events
immunotherapy
metastatic renal cell carcinoma
sarcoid‐like reactions
url https://doi.org/10.1002/ccr3.5960
work_keys_str_mv AT victoriapurcell suspectedimmunecheckpointinhibitorinducedpulmonarysarcoidreactioninmetastaticrenalcellcarcinoma
AT beatricepreti suspectedimmunecheckpointinhibitorinducedpulmonarysarcoidreactioninmetastaticrenalcellcarcinoma
AT ricardofernandes suspectedimmunecheckpointinhibitorinducedpulmonarysarcoidreactioninmetastaticrenalcellcarcinoma